Skip to main content

Table 2 Rates of events in individual studies

From: Benefits and harms of citrate locking solutions for hemodialysis catheters: a systematic review and meta-analysis

Study

Citrate

Heparin

Events

Catheter days

Events/1000 catheter days

Events

Catheter days

Events/1000 catheter days

Mortality

Power

5

19008

0.26

5

17100

0.29

Weijmer

13

8181

1.59

18

8049

2.24

MacRae

4

2272

1.76

5

1818

2.75

Bacteremia

Power

13

19008

0.68

12

17100

0.70

Weijmer

9

8181

1.10

33

8049

4.10

MacRae

5

2272

2.20

6

1818

3.30

Access-related hospitalization

Power

17

19008

0.89

12

17100

0.70

Weijmer

6

8181

0.70

21

8049

2.70

Catheter replacement

Buturovic

1

2272

1.96

1

1818

4.35

MacRae

8

2272

3.52

5

1818

2.75

Weijmer

27

8181

3.21

29

8049

3.56

Thrombolysis

MacRae

13

2272

5.72

13

1818

7.15

Power

1

19008

0.06

1

17100

0.04

Weijmer

69

8181

8.28

63

8049

7.88

Bleeding

MacRae

25

2272

11.00

37

1818

20.35

Weijmer

5

8181

0.60

16

8049

2.00